A case applied with decompensated heart failure findings diagnosed as primary effusion lymphoma


Yildirim N. D., Bicakci E., Elverdi T., Yenerel M. N., Kucukkaya R. D., Dogan O., ...More

TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI, vol.25, no.2, pp.152-155, 2008 (SCI-Expanded, Scopus, TRDizin)

  • Publication Type: Article / Article
  • Volume: 25 Issue: 2
  • Publication Date: 2008
  • Journal Name: TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.152-155
  • Istanbul University Affiliated: Yes

Abstract

Primary Effusion Lymphoma (PEL) is an infrequent subtype of Non-Hodgkin's Lymphoma which is characterized by lymphomatous effusions in body cavities, not-associated with mass lesions. Generally PEL is reported in immunocompromised patients infected with human immunodeficiency virus (HIV) and Human Herpes Virus-8 (HHV-8). Recently HIV and HHV-8 negative cases were also reported. Here, we report a 76 year-old man with HIV and HHV-8 negative PEL successfully treated with R-COP chemotherapy protocol.